WINDLAS BIOTECH LIMITED Financial Ratios
WINDLAS · Healthcare · Current price ₹844.25
P/E ratio
29.2x
P/B ratio
2.9x
ROE
11.4%
ROCE
17.0%
Debt / Equity
0.06
Dividend yield
0.8%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 29.2x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 2.9x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 11.4% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 17.0% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.06 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with WINDLAS BIOTECH LIMITED's latest numbers.
WINDLAS BIOTECH LIMITED profitability
WINDLAS BIOTECH LIMITED generates a return on equity of 11.4% and a return on capital employed of 17.0%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.06 and a P/E of 29.2x, WINDLAS BIOTECH LIMITED is conservatively financed. Our overall business-quality score for the company is 3.7 / 10.
Understand the ratios
More on WINDLAS BIOTECH LIMITED
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.